NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.9800
-0.0200 (-2.00%)
Sep 30, 2025, 2:45 PM EDT
-2.00%
Market Cap80.77M
Revenue (ttm)n/a
Net Income (ttm)-8.62M
Shares Out82.41M
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,475
Average Volume88,997
Open1.0100
Previous Close1.0000
Day's Range0.9700 - 1.0100
52-Week Range0.5300 - 1.1400
Beta0.09
RSI55.54
Earnings DateNov 28, 2025

About NurExone Biologic

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It develops and commercializes the ExoTherapy platform for production of exosome-loaded nanodrugs. The company is also developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis caused by spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat traumatic brain injuries and other ne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 16
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.